Analysis-Obesity battle heats up again as Novo claws way back into race with Lilly

Obesity battle heats up again as Novo claws its way back into race with Lilly

Novo Nordisk is getting a boost from its new Wegovy weight-loss pill that ​is holding onto its lead against Eli Lilly's more recently launched Foundayo.

Analysis-Obesity battle heats up again as Novo claws way back into race with Lilly

By Maggie Fick and Bhanvi Satija LONDON, Aug 3 - Novo Nordisk investors have found little cause for optimism during a bruising two-year period of profit warnings, leadership upheaval and a sliding share price as rival Eli Lilly streaked ahead. Now they...